GlassScriptPhysician profile
Philip S Lee
NPI 1972890879
$5,433.50
in general payments reported to CMS, 2019-2025
12 companies · $780 in 2025
The $780 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,057 · 2020: $783 · 2021: $234 · 2022: $1,010 · 2023: $717 · 2024: $852 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,557 · Travel and Lodging: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,556.77 |
| Travel and Lodging | $793.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,054.41 | 2021-2025 | Mazor X System, Cd Horizon Spinal System, Strata |
| Abbott Laboratories | $733.02 | 2019-2022 | |
| Stryker Corporation | $598.15 | 2019-2022 | |
| Livanova USA, INC. | $589.41 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Medtronic USA, INC. | $361.63 | 2019-2020 | |
| Carl Zeiss Meditec, INC. | $327.78 | 2019 | |
| Si-Bone, INC. | $266.17 | 2019-2022 | |
| Monteris Medical Corporation | $189.97 | 2019-2023 | Neuroblate |
| Boston Scientific Corporation | $137.52 | 2025 | General - Pain Management |
| Zimmer Biomet Holdings, INC. | $98.00 | 2022 | |
| Integra Lifesciences Corporation | $60.83 | 2020 | |
| Neuropace, INC. | $16.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.